ITEM 2.02 Results of Operations and Financial Condition
On February 12, 2020, Teva Pharmaceutical Industries Ltd. issued a press release
announcing its financial results for the period ended December 31, 2019. A copy
of the press release is furnished as Exhibit 99.1 to this Current Report on Form
8-K and the information contained therein is incorporated herein by reference.
The information included in this Item 2.02 is being furnished to the Securities
and Exchange Commission and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing.
ITEM 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit
No. Description of Document
99.1 Teva Reports 2019 Full Year and Fourth Quarter Financial Results
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses